Emerald Advisers’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $243K | Hold |
|
|||||
|
2025
Q2 | $193K | Hold |
|
|||||
|
2025
Q1 | $152K | Hold |
|
|||||
|
2024
Q4 | $177K | Hold |
|
|||||
|
2024
Q3 | $181K | Hold |
|
|||||
|
2024
Q2 | $142K | Hold |
|
|||||
|
2024
Q1 | $189K | Hold |
|
|||||
|
2023
Q4 | $92.6K | Hold |
|
|||||
|
2023
Q3 | $65.2K | Sell |
|
|||||
|
2023
Q2 | $236K | Hold |
|
|||||
|
2023
Q1 | $241K | Sell |
|
|||||
|
2022
Q4 | $2.71M | Sell |
|
|||||
|
2022
Q3 | $6.25M | Buy |
|
|||||
|
2022
Q2 | $5.89M | Buy |
|
|||||
|
2022
Q1 | $6.39M | Buy |
|
|||||
|
2021
Q4 | $7.37M | Buy |
|
|||||
|
2021
Q3 | $8.5M | Sell |
|
|||||
|
2021
Q2 | $17.3M | Sell |
|
|||||
|
2021
Q1 | $21.2M | Buy |
|
|||||
|
2020
Q4 | $24.6M | Buy |
|